ACIU
ACIU
CH0329023102
AC Immune SA
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 80/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±78.5% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 1.6x as much as the broader market.

Beta (Market Relation)
1.55x
Above average
Volatility (5Y p.a.)
78.5% p.a.
5-Year Horizon
Max Drawdown (5Y)
-80.4%
5-Year Horizon
Sharpe Ratio
-0.25
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -27.6%
3 Years 73.3% -70.4% -0.04 -0.1%
5 Years 78.5% -80.4% -0.25 -16.9%
10 Years 78.8% -91.0% -0.24 -16.4%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
High market risk: Beta of 1.55 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (78.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -91.0% in the extended horizon.
ende